Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer (Q36086444)

12 August 2017

1 reference

title

Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer (English)

1 reference

12 August 2017

Diego F Calvisi

1

1 reference

12 August 2017

Snorri S Thorgeirsson

series ordinal

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

12 August 2017

published in

Toxicologic Pathology

1 reference

12 August 2017

volume

33

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

181-184

1 reference

Function and activation of NF-kappa B in the immune system

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080/01926230590522095

Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230590522095

Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230590522095

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230590522095

Disruption of redox homeostasis in the transforming growth factor-alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230590522095

Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230590522095

Roles of Akt/PKB and IKK complex in constitutive induction of NF-kappaB in hepatocellular carcinomas of transforming growth factor alpha/c-myc transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230590522095

Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230590522095

Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230590522095

Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230590522095

Transforming growth factor-beta: possible roles in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230590522095

Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230590522095

Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-alpha in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230590522095

Beta-catenin (Ctnnb1) gene mutations in diethylnitrosamine (DEN)-induced liver tumors in male F344 rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230590522095

10.1080/01926230590522095

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference